Developer docs
API playgroundTry for free, no card

Search company profiles

Farmaceutici Damor

Full company profile

uuid000khb8

Namestring
Farmaceutici Damor
Websiteurl
damorpharma.it
Company typeenum
Private
Founded yearint
1943
Descriptiontext

Farmaceutici Damor S.p.A. is a privately held Italian pharmaceutical company founded in 1943 and headquartered in Naples, with a secondary office in Monza. The company develops, manufactures, and distributes bio-pharmaceutical products built around a proprietary active pharmaceutical ingredient, the Estratto Acquoso di Triticum Vulgare (aqueous wheat extract), and the related "Stimoline" compound family it has researched since 1946 in line with Prof. Vladimir Filatov's theories. Its product portfolio spans four categories: pharmaceutical specialties, medical devices (centered on the Fitostimoline line of gauzes, creams, hydrogels, sprays, and proctogel, plus the Clarema Fitogel), food supplements, and cosmetics. Manufacturing is conducted in-house at the GMP-certified Naples facility, which holds ISO 9001, ISO 13485, ISO 14001, and ISO 45001 certifications as well as PLANT BASED conformity.

The company's go-to-market is a direct distribution model through Italian pharmacies and healthcare providers, with no disclosed international presence beyond Italy. Akademy Pharma, an in-house R&D initiative, formalizes collaboration with university experts for both technical and scientific development of new products. In 2019, Farmaceutici Damor entered an EU-funded productive investment partnership with Invitalia and the Italian Ministry of Economic Development to requalify part of its Naples industrial facility and acquire equipment to increase manufacturing volumes, signaling capacity-led growth rather than aggressive market expansion. Pricing is not publicly disclosed and no revenue figures are available; the company operates as a focused, niche Italian pharma with strong regulated-market credentials but limited geographic diversification.

Short descriptiontext

Farmaceutici Damor is a privately held Italian pharmaceutical company founded in 1943, manufacturing and distributing bio-pharmaceutical products based on its proprietary Triticum Vulgare extract API across medicines, medical devices, food supplements, and cosmetics through Italian pharmacies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNapoli, Italy
HQ citystring
Napoli
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, bio-pharmaceutical products, wound care medical devices, dermatological products, natural pharmaceutical extracts
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Akademy Pharma
Description

A research and development initiative that develops products with support from the best university experts participating in both technical and scientific development phases.

damorpharma.it
+2 more records
Core offering1 text field

Farmaceutici Damor manufactures bio-pharmaceutical products based on its proprietary Estratto Acquoso di Triticum Vulgare (Stimoline compounds) discovered in 1946. The company produces pharmaceutical specialties, medical devices (wound care and dermatological products such as Fitostimoline and Clarema lines), food supplements, and cosmetics, integrating the full production cycle from API to finished product.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Farmaceutici Damor is an Italian pharmaceutical company with a global vision that develops and manufactures a portfolio of bio-pharmaceutical products. The company's core focus is on natural bio-pharmaceutical innovation, particularly centered around the Triticum Vulgare extract (inspired by Prof. Vladimir Filatov's 'Stimoline' theories). The product portfolio spans four main categories: (1) Specialità Medicinali - pharmaceutical specialties including their API (Estratto Acquoso di Triticum Vulgare); (2) Dispositivi Medici - medical devices including the Fitostimoline line (gauze, cream, hydrogel, spray, proctogel) and Clarema Fitogel for dermatological use; (3) Integratori Alimentari - food supplements; and (4) Cosmetici - cosmetic products. The company operates through AKADEMY PHARMA, which collaborates with university experts for product development.

Product and service6 records
1Fitostimoline Plus Spray
CategoryMedical Device
Description

A spray formulation medical device for wound care and dermatological use, part of the Fitostimoline product line based on Triticum Vulgare aqueous extract.

2Clarema Fitogel
CategoryMedical Device
Description

A hydrophilic gel medical device in an aluminum tube for dermatological and skin care applications.

3Specialità Medicinali
CategoryPharmaceutical
Description

Prescription and over-the-counter pharmaceutical specialties produced by Farmaceutici Damor, including products based on their core API Estratto Acquoso di Triticum Vulgare.

4Dispositivi Medici
CategoryMedical Device
Description

Medical devices including wound care products, dermatological gels, and sprays under brands like Fitostimoline (gauze, cream, hydrogel, spray, proctogel) and Clarema.

5Integratori Alimentari
CategoryFood Supplement
Description

Food supplements and nutritional products manufactured by Farmaceutici Damor.

6Cosmetici
CategoryCosmetic
Description

Cosmetic products formulated and manufactured by Farmaceutici Damor.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italian specialty pharmaceutical company of comparable mid-market size with a similar mix of prescription pharmaceuticals, medical devices, and healthcare products. Closely comparable business model and channel structure to Farmaceutici Damor.

2Dompé Farmaceutici
TypeDirect peer
Description

Italian biopharmaceutical company with branded specialty pharma, OTC, and medical device offerings. Comparable in being an Italy-headquartered, privately controlled specialty pharma with integrated manufacturing.

TypeDirect peer
Description

Swiss-Italian privately held specialty pharma with a portfolio spanning prescription drugs, medical devices, and consumer health. Comparable mid-size specialty structure with adjacent therapeutic and dermocosmetic focus.

TypeDirect peer
Description

Global medical device specialist in advanced wound care, ostomy, and continence care. Direct competitor to Damor's Fitostimoline wound care franchise in advanced wound dressings and skin integrity products.

TypeDirect peer
Description

Swedish-headquartered global leader in wound care and surgical solutions. Directly comparable as a wound care and dermatology medical device specialist competing with Fitostimoline and Clarema in the same indications.

TypeDirect peer
Description

Danish global medical device company with a strong wound and skin care franchise alongside ostomy and continence. Comparable in wound/skin care medical device positioning and dermatology-adjacent product strategy.

TypeBroad incumbent
Description

Privately held Italian pharmaceutical group with a broader prescription and consumer health portfolio. Comparable Italian specialty pharma heritage and channel strategy but operating at significantly greater scale.

TypeBroad incumbent
Description

Large privately held Italian pharmaceutical group with specialty and rare disease franchises. Comparable Italian family-controlled pharma heritage but with a substantially larger and more diversified footprint.

TypeDirect peer
Description

French-headquartered wound care medical device specialist (part of Urgo Group). Directly comparable in advanced wound dressings, dermatology, and skin integrity products targeting overlapping customer segments.

TypeBroad incumbent
Description

Polish-headquartered European specialty pharmaceutical manufacturer with OTC and prescription generics. Comparable European mid-large specialty pharma with a manufacturing-led, multi-category portfolio strategy.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Farmaceutici Damor

Pharmaceutical Manufacturingdamorpharma.it

Farmaceutici Damor is a privately held Italian pharmaceutical company founded in 1943, manufacturing and distributing bio-pharmaceutical products based on its proprietary Triticum Vulgare extract API across medicines, medical devices, food supplements, and cosmetics through Italian pharmacies.

What Farmaceutici Damor does

Farmaceutici Damor S.p.A. is a privately held Italian pharmaceutical company founded in 1943 and headquartered in Naples, with a secondary office in Monza. The company develops, manufactures, and distributes bio-pharmaceutical products built around a proprietary active pharmaceutical ingredient, the Estratto Acquoso di Triticum Vulgare (aqueous wheat extract), and the related "Stimoline" compound family it has researched since 1946 in line with Prof. Vladimir Filatov's theories. Its product portfolio spans four categories: pharmaceutical specialties, medical devices (centered on the Fitostimoline line of gauzes, creams, hydrogels, sprays, and proctogel, plus the Clarema Fitogel), food supplements, and cosmetics. Manufacturing is conducted in-house at the GMP-certified Naples facility, which holds ISO 9001, ISO 13485, ISO 14001, and ISO 45001 certifications as well as PLANT BASED conformity.

The company's go-to-market is a direct distribution model through Italian pharmacies and healthcare providers, with no disclosed international presence beyond Italy. Akademy Pharma, an in-house R&D initiative, formalizes collaboration with university experts for both technical and scientific development of new products. In 2019, Farmaceutici Damor entered an EU-funded productive investment partnership with Invitalia and the Italian Ministry of Economic Development to requalify part of its Naples industrial facility and acquire equipment to increase manufacturing volumes, signaling capacity-led growth rather than aggressive market expansion. Pricing is not publicly disclosed and no revenue figures are available; the company operates as a focused, niche Italian pharma with strong regulated-market credentials but limited geographic diversification.

Farmaceutici Damor firmographics

Firmographics
Name
Farmaceutici Damor
Website
https://damorpharma.it
Company type
Private
Founded year
1943
Operating status
Operating
Headcount range
101–250 employees
Short description
Farmaceutici Damor is a privately held Italian pharmaceutical company founded in 1943, manufacturing and distributing bio-pharmaceutical products based on its proprietary Triticum Vulgare extract API across medicines, medical devices, food supplements, and cosmetics through Italian pharmacies.
Ownership category
akta.pro rank

Where Farmaceutici Damor is headquartered

Location

Headquarters

HQ city
Napoli
HQ country
Italy
HQ region
Europe

Offices2 records

Markets served

Farmaceutici Damor business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels2 records

Farmaceutici Damor product offering

Product offering

Core offering

Farmaceutici Damor manufactures bio-pharmaceutical products based on its proprietary Estratto Acquoso di Triticum Vulgare (Stimoline compounds) discovered in 1946. The company produces pharmaceutical specialties, medical devices (wound care and dermatological products such as Fitostimoline and Clarema lines), food supplements, and cosmetics, integrating the full production cycle from API to finished product.

Product overview

Farmaceutici Damor is an Italian pharmaceutical company with a global vision that develops and manufactures a portfolio of bio-pharmaceutical products. The company's core focus is on natural bio-pharmaceutical innovation, particularly centered around the Triticum Vulgare extract (inspired by Prof. Vladimir Filatov's 'Stimoline' theories). The product portfolio spans four main categories: (1) Specialità Medicinali - pharmaceutical specialties including their API (Estratto Acquoso di Triticum Vulgare); (2) Dispositivi Medici - medical devices including the Fitostimoline line (gauze, cream, hydrogel, spray, proctogel) and Clarema Fitogel for dermatological use; (3) Integratori Alimentari - food supplements; and (4) Cosmetici - cosmetic products. The company operates through AKADEMY PHARMA, which collaborates with university experts for product development.

Differentiator

Problem solved

Functional benefit

Brands

  • Akademy Pharma: A research and development initiative that develops products with support from the best university experts participating in both technical and scientific development phases.
  • Fitostimoline
  • Clarema

Products and services

  • Fitostimoline Plus Spray A spray formulation medical device for wound care and dermatological use, part of the Fitostimoline product line based on Triticum Vulgare aqueous extract.
  • Clarema Fitogel A hydrophilic gel medical device in an aluminum tube for dermatological and skin care applications.
  • Specialità Medicinali Prescription and over-the-counter pharmaceutical specialties produced by Farmaceutici Damor, including products based on their core API Estratto Acquoso di Triticum Vulgare.
  • Dispositivi Medici Medical devices including wound care products, dermatological gels, and sprays under brands like Fitostimoline (gauze, cream, hydrogel, spray, proctogel) and Clarema.
  • Integratori Alimentari Food supplements and nutritional products manufactured by Farmaceutici Damor.
  • Cosmetici Cosmetic products formulated and manufactured by Farmaceutici Damor.

Companies that use Farmaceutici Damor

Customer profile

Segments1 record

Ideal customer profiles2 records

Farmaceutici Damor technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Farmaceutici Damor partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Farmaceutici Damor competitors and assessment

Company assessment

Direct peers

  • Fidia Farmaceutici: Italian specialty pharmaceutical company of comparable mid-market size with a similar mix of prescription pharmaceuticals, medical devices, and healthcare products. Closely comparable business model and channel structure to Farmaceutici Damor.
  • Dompé Farmaceutici: Italian biopharmaceutical company with branded specialty pharma, OTC, and medical device offerings. Comparable in being an Italy-headquartered, privately controlled specialty pharma with integrated manufacturing.
  • IBSA Farmaceutici: Swiss-Italian privately held specialty pharma with a portfolio spanning prescription drugs, medical devices, and consumer health. Comparable mid-size specialty structure with adjacent therapeutic and dermocosmetic focus.
  • ConvaTec: Global medical device specialist in advanced wound care, ostomy, and continence care. Direct competitor to Damor's Fitostimoline wound care franchise in advanced wound dressings and skin integrity products.
  • Mölnlycke Health Care: Swedish-headquartered global leader in wound care and surgical solutions. Directly comparable as a wound care and dermatology medical device specialist competing with Fitostimoline and Clarema in the same indications.
  • Coloplast: Danish global medical device company with a strong wound and skin care franchise alongside ostomy and continence. Comparable in wound/skin care medical device positioning and dermatology-adjacent product strategy.
  • Urgo Medical: French-headquartered wound care medical device specialist (part of Urgo Group). Directly comparable in advanced wound dressings, dermatology, and skin integrity products targeting overlapping customer segments.

Broad incumbents

  • Angelini Pharma: Privately held Italian pharmaceutical group with a broader prescription and consumer health portfolio. Comparable Italian specialty pharma heritage and channel strategy but operating at significantly greater scale.
  • Chiesi Farmaceutici: Large privately held Italian pharmaceutical group with specialty and rare disease franchises. Comparable Italian family-controlled pharma heritage but with a substantially larger and more diversified footprint.
  • Polpharma: Polish-headquartered European specialty pharmaceutical manufacturer with OTC and prescription generics. Comparable European mid-large specialty pharma with a manufacturing-led, multi-category portfolio strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Farmaceutici Damor social profiles

Digital presence

Farmaceutici Damor compliance and trust

Trust signal

Compliance9 records

Farmaceutici Damor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Farmaceutici Damor leadership team

Management profile

Number of profiles

Farmaceutici Damor funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Farmaceutici Damor M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farmaceutici Damor

What does Farmaceutici Damor do?

Farmaceutici Damor manufactures bio-pharmaceutical products based on its proprietary Estratto Acquoso di Triticum Vulgare (Stimoline compounds) discovered in 1946. The company produces pharmaceutical specialties, medical devices (wound care and dermatological products such as Fitostimoline and Clarema lines), food supplements, and cosmetics, integrating the full production cycle from API to finished product.

Is Farmaceutici Damor a public or private company?

Farmaceutici Damor is a private company. It is classified as unknown and is currently operating.

When was Farmaceutici Damor founded?

Farmaceutici Damor was founded in 1943. It employs 101 to 250 people.

Where is Farmaceutici Damor based?

Farmaceutici Damor is headquartered in Napoli, Italy, in the Europe region.

Who are Farmaceutici Damor's main competitors?

Direct peers on record are Fidia Farmaceutici, Dompé Farmaceutici, IBSA Farmaceutici, ConvaTec, Mölnlycke Health Care, Coloplast and Urgo Medical. Broad incumbents are Angelini Pharma, Chiesi Farmaceutici and Polpharma.

Does Farmaceutici Damor have an API?

No public API is recorded for Farmaceutici Damor.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales